AT388951T

Dpp-iv-inhibiting purine derivatives for the treatment of diabetes

Abstract

In activity the present invention therapeutically [the formula I] And in order to carry out medical treatment medical treatment of the disease relevant to the protein which receives inactivation by DPP-IV like the pharmacological composite containing alternative inhibitor and this compound, 2 type diabetes, and overweight, And it is related with use of this compound for manufacturing the medicine for treating this disease.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

10 members in 6 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
PA200101049DenmarkA
PA200200180DenmarkA

Members10

Family members, oldest first
DocumentOfficeKind
WO03004496A1World Intellectual Property Organization (WIPO)A1
US2003105077A1United States of AmericaA1
EP1404675A1European Patent Office (EPO)A1
JP2005502624AJapanA
US6869947B2United States of AmericaB2
US2005148606A1United States of AmericaA1
US7192952B2United States of AmericaB2
EP1404675B1European Patent Office (EPO)B1
AT388951TThis recordAustriaT
DE60225556D1GermanyD1